<HTML xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en" dir="ltr">
<style type="text/css">
A:before { content:' '; } 
A:after { content:' '; } 
SPAN:before { content:' '; } 
SPAN:after { content:' '; } 
</style>
<BODY class="mediawiki  ltr ns-0 ns-subject page-Team_EPF_Lausanne_Project_immuno"><DIV id="globalWrapper"><DIV id="top-section"><DIV id="p-logo"><A href="/Main_Page" title="Main Page">&quot;
	    </A></DIV><DIV id="menubar" class="left-menu noprint"><UL><LI class="selected"><A href="/Team:EPF_Lausanne/Project_immuno">Page               </A></LI><LI class="new"><A href="/wiki/index.php?title=Talk:Team:EPF_Lausanne/Project_immuno&amp;action=edit&amp;redlink=1">Discussion               </A></LI><LI><A href="/wiki/index.php?title=Team:EPF_Lausanne/Project_immuno&amp;action=edit">View source               </A></LI><LI><A href="/wiki/index.php?title=Team:EPF_Lausanne/Project_immuno&amp;action=history">History               </A></LI><LI style="color:#808080;cursor:default">teams</LI></UL></DIV><DIV class="right-menu noprint" id="menubar"><UL><LI id="pt-login"><A href="/wiki/index.php?title=Special:UserLogin&amp;returnto=Team:EPF_Lausanne/Project_immuno" title="You are encouraged to log in; however, it is not mandatory [o]" accesskey="o">Log in</A></LI></UL></DIV><DIV id="search-controls" class="noprint"><FORM action="/Special:Search" id="searchform"> </FORM></DIV></DIV><DIV id="content"><H1 class="firstHeading">Team:EPF Lausanne/Project immuno</H1><DIV id="bodyContent"><H3 id="siteSub" class="noprint">From 2010.igem.org</H3><DIV class="EPFL_content"><TABLE id="toc" class="toc"><TBODY><TR><TD><DIV id="toctitle"><H2>Contents</H2></DIV><UL><LI class="toclevel-1 tocsection-1"><A href="#Proteins"><SPAN class="tocnumber">1</SPAN><SPAN class="toctext">Proteins</SPAN></A></LI><LI class="toclevel-1 tocsection-2"><A href="#Results"><SPAN class="tocnumber">2</SPAN><SPAN class="toctext">Results</SPAN></A></LI><LI class="toclevel-2 tocsection-3"><A href="#A:_The_Immunotoxin_is_expressed_and_appears_in_the_supernatant"><SPAN class="tocnumber">2.1</SPAN><SPAN class="toctext">A: The Immunotoxin is expressed and appears in the supernatant</SPAN></A></LI><LI class="toclevel-2 tocsection-4"><A href="#B:_The_P-proteins_are_not_expressed"><SPAN class="tocnumber">2.2</SPAN><SPAN class="toctext">B: The P-proteins are not expressed</SPAN></A></LI></UL><LI class="toclevel-1 tocsection-5"><A href="#References"><SPAN class="tocnumber">3</SPAN><SPAN class="toctext">References</SPAN></A></LI></TD></TR></TBODY></TABLE><H1><SPAN class="mw-headline" id="Proteins">Proteins</SPAN></H1><P>We have chosen two different ways to target the parasite <I>P.falciparum</I> and prevent the malaria transmission through mosquitos. Our engineered bacteria could express either an immunotoxin, or two &quot;p-proteins&quot;, or even both for maximum efficiency. We tried to express all of these proteins using the C3 plasmid incorporating the <A href="https://2010.igem.org/Image:EPFL_CFP_prom.png" class="external text" rel="nofollow">strong promoter</A>, a constitutive sequence for greater level of expression. 
</P><P>The <A href="https://2010.igem.org/wiki/index.php?title=Team:EPF_Lausanne/Project/Background" class="external text" rel="nofollow">Immunotoxin</A> is one of our tools to block transmission of malaria parasite in mosquitos. It is composed of two main parts : The first one is a single-chain antibody fragment (scFv) directed to Pbs2l, which is a surface membrane protein of <I>Plasmodium berghei</I>. The second part is a lytic peptide, Shiva-1, which acts by forming “pores” on the parasite’s membrane. The immunotoxin is supposed to specifically target and lyse the parasite.
</P><DIV class="thumb tright"><DIV class="thumbinner" style="width:682px;"><DIV class="thumbcaption">The different domaines of the immunotoxin. For more details and the sequence see the <A href="https://2010.igem.org/wiki/index.php?title=Team:EPF_Lausanne/Project/Background" class="external text" rel="nofollow">background</A> section.</DIV></DIV></DIV><P>
In parallel to the immunotoxin we thought of a different way of blocking the <I>P.falciparum</I> by using  
<A href="https://2010.igem.org/wiki/index.php?title=Team:EPF_Lausanne/Project/Background" class="external text" rel="nofollow">P25 and P28</A> which belong to a class of important proteins expressed on the membrane of the Plasmodium. We called them the &quot;P-proteins&quot;. They are mainly expressed on the mosquito-stage of the parasite (ookinete).
The Plasmodium normally uses these P-protein to interact with the epithelium in order to go through it.
</P><P>
Now if Asaia starts to produce a high amout of these proteins, the interactions will be disrupted and the plasmodium will not propagate through the mosquito's epithelium.
</P><H1><SPAN class="mw-headline" id="Results">Results</SPAN></H1><H2><SPAN class="mw-headline" id="A:_The_Immunotoxin_is_expressed_and_appears_in_the_supernatant">A: The Immunotoxin is expressed and appears in the supernatant</SPAN></H2><DIV class="thumb tright"><DIV class="thumbinner" style="width:302px;"><DIV class="thumbcaption"><B>Growth curve of <I>E. coli</I> expressing the Immunotoxin:</B> In blue, we can see the growth curve of <I>E. coli</I> containing the empty C3 plasmid. In red, we can see the growth of <I>E. coli</I> transformed with the C3 plasmid containing the Immunotoxin sequence. We could conclude that the expression of the Immunotoxin in high concetrations may prevent <I>E. coli</I> from growing.</DIV></DIV></DIV><P>We tested expression of the immunotoxin in <I>E. coli</I> (see <A href="https://2010.igem.org/wiki/index.php?title=Team:EPF_Lausanne/Project/Materials_Methods" class="external text" rel="nofollow">Materials and Methods</A> for details). In a western blot analysis of whole cell lysates we could see bands corresponding to full length immunotoxin and possibly degraded fragments of the protein (see gel image below).
</P><P>The immunotoxin contains a PelB sequence that targets it for secretion into the periplasm. We concentrated the supernatant of both the immunotoxin and a control culture by running it through a filtering device with a 5 kDa cut-off. Running a western blot with these samples (see gel image below) we verified that the immunotoxin was also found in the supernatant. 
</P><P>We observed that the cells containing the immunotoxin plasmid grew a lot slower than the control (see figure). This is probably due to the fact that the cells are producing the immunotoxin. Furthermore at high concentrations the immunotoxin might lyse the cells. 
</P><DIV class="center"><DIV class="thumb tnone"><DIV class="thumbinner" style="width:402px;"><DIV class="thumbcaption"><B>Gel1 (Lysates):</B> We can see distinct molecular fragments in the immunotoxin lane: The upper fragments (marked with red and purple arrows) match the molecular size of the immunotoxin of about 39 kDa. For the shorter of the two fragments the export tag pelB may have been cut off. The smaller sized fragment (green arrow) of about 20 kDa is most probably part of the degraded immunotoxin. <B>Gel2 (Supernatants):</B> A fragment of the correct size is detected in the supernatant. The smaller fragments (green and yellow arrows) probably correspond to smaller parts of the degraded immunotoxin. The band present in all lanes corresponds to a biotinylated protein which is detected by the secondary antibodies.</DIV></DIV></DIV></DIV><H2><SPAN class="mw-headline" id="B:_The_P-proteins_are_not_expressed">B: The P-proteins are not expressed </SPAN></H2><P>The same experiments were conducted for the p-proteins <A href="https://2010.igem.org/wiki/index.php?title=Team:EPF_Lausanne/Project/Background" class="external text" rel="nofollow">p25 and p28</A>. No bands were detected on the western blots (see figure) which leads us to the conclusion that these proteins were only very weakly expressed or not at all. This might be explained by the fact that we took the native sequence from <I>Plasmodium falciparum</I>. The genome of <I>Plasmodium falciparum</I> is very A-T-rich (<A href="http://areslab.ucsc.edu/cgi-bin/hgGateway" class="external text" rel="nofollow">UCSC Malaria Genome Browser</A>).
</P><P>We think that expression of p25 and p28 may be improved by codon optimizing it for expression in bacteria like <I>E. coli</I> and <I>Asaia</I> as we did with the immunotoxin. 
Additional to the Western Blots, to rule out the possibility that concentration was too low, we attempted a protein purification (following the <A href="http://openwetware.org/wiki/Knight:Purification_of_His-tagged_proteins/Denaturing" class="external text" rel="nofollow">Knight protocol</A>) from a large culture volume (see figure) using Ni-NTA columns. 
</P><DIV class="center"><DIV class="thumb tnone"><DIV class="thumbinner" style="width:702px;"><DIV class="thumbcaption"><B>Gel1 (Western Blot):</B> There are no fragments detected neither for p25 nor for p28. The fragment detected for the positive control around the weight expected verifies the success of the analysis. <B>Gel2 (Silver Stain):</B> We tried to purify the proteins in order to exclude the possibility that the proteins were not detected due to low concentration. Protein purification was followed by silver stain analysis. Again, no bands were detected on the gel.</DIV></DIV></DIV></DIV><H1><SPAN class="mw-headline" id="References">References</SPAN></H1><UL><LI><A href="http://www.sciencedirect.com/science?_ob=ArticleURL&amp;_udi=B6T29-42JHDJD-9&amp;_user=10&amp;_coverDate=03%2F31%2F2001&amp;_rdoc=1&amp;_fmt=high&amp;_orig=search&amp;_origin=search&amp;_sort=d&amp;_docanchor=&amp;view=c&amp;_acct=C000050221&amp;_version=1&amp;_urlVersion=0&amp;_userid=10&amp;md5=5f4b78b08a1846e241faaed33bc76cb3&amp;searchtype=a" class="external text" rel="nofollow">1. Shigeto Yoshida, <I>Bacteria expressing single-chain immunotoxin inhibit malaria parasite development in mosquitoes</I>, Molecular and Biochemical Parasitology (2001)</A></LI><LI><A href="http://www.nature.com/emboj/journal/v20/n15/full/7593895a.html" class="external text" rel="nofollow">2. Ana M. Tomas, Gabriele Margos, Robert E. Sinden, <I>P25 and P28 proteins of the malaria ookinete surface have multiple and partially redundant functions</I>, The EMBO Journal (2001)</A></LI><LI><A href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1951121/?tool=pubmed" class="external text" rel="nofollow">3. Ajay K. Saxena, Yimin Wu, and David N. Garboczi, <I>Plasmodium P25 and P28 Surface Proteins: Potential Transmission-Blocking Vaccines</I>, Eukaryot Cell (2007)</A></LI><LI><A href="http://www.nature.com/nsmb/journal/v13/n1/full/nsmb1024.html" class="external text" rel="nofollow">4. Ajay et al., The essential mosquito-stage P25 and P28 proteins from Plasmodium form tile-like triangular prisms, natures structural &amp; molecular biology, 2005</A></LI></UL></DIV><DIV class="printfooter">
Retrieved from &quot;<A href="http://2010.igem.org/Team:EPF_Lausanne/Project_immuno">http://2010.igem.org/Team:EPF_Lausanne/Project_immuno</A>&quot;</DIV></DIV></DIV><DIV id="footer-box" class="noprint"><DIV id="footer"><UL id="f-list"><LI id="t-recentchanges"><A href="/Special:RecentChanges" title="Recent changes">Recent changes</A></LI><LI id="t-whatlinkshere"><A href="/Special:WhatLinksHere/Team:EPF_Lausanne/Project_immuno" title="List of all wiki pages that link here [j]" accesskey="j">What links here</A></LI><LI id="t-recentchangeslinked"><A href="/Special:RecentChangesLinked/Team:EPF_Lausanne/Project_immuno" title="Recent changes in pages linked from this page [k]" accesskey="k">Related changes</A></LI><LI id="t-specialpages"><A href="/Special:SpecialPages" title="List of all special pages [q]" accesskey="q">Special pages</A></LI><LI><A href="/Special:Preferences">My preferences</A></LI></UL></DIV><DIV id="footer"><UL id="f-list"><LI id="t-print"><A href="/wiki/index.php?title=Team:EPF_Lausanne/Project_immuno&amp;printable=yes" title="Printable version of this page [p]" accesskey="p">Printable version</A></LI><LI id="t-permalink"><A href="/wiki/index.php?title=Team:EPF_Lausanne/Project_immuno&amp;oldid=203003" title="Permanent link to this revision of the page">Permanent link</A></LI><LI id="privacy"><A href="/2010.igem.org:Privacy_policy" title="2010.igem.org:Privacy policy">Privacy policy</A></LI><LI id="disclaimer"><A href="/2010.igem.org:General_disclaimer" title="2010.igem.org:General disclaimer">Disclaimers</A></LI></UL></DIV></DIV></DIV></BODY></HTML>